Download PDF
Viszeralchirurgie 2005; 40(4): 272-278
DOI: 10.1055/s-2005-836648
Originalarbeit

© Georg Thieme Verlag Stuttgart · New York

Stellenwert der Lymphadenektomie im Behandlungskonzept des Magenkarzinoms

Lymphadenectomy for Gastric CarcinomaS. P. Mönig1 , E. Bollschweiler1 , A. H. Hölscher1
  • 1Klinik und Poliklinik für Visceral- und Gefäßchirurgie der Universität zu Köln
Further Information

Publication History

Publication Date:
13 September 2005 (online)

    Permissions and Reprints

Zusammenfassung

Der Stellenwert der erweiterten Lymphadenektomie kann auch nach Vorliegen eines Cochrane-Reviews nicht abschließend bewertet werden. Verschiedene nichtrandomisierte japanische und europäische Studien konnten einen Prognosevorteil nach D2-Lymphadenektomie aufzeigen. Zwei randomisierte europäische Studien berichteten über eine signifikant erhöhte Morbidität und Mortalität nach D2-Lymphadenektomie ohne Prognosegewinn in dieser Gruppe. Lediglich in der N2-Subgruppe ist eine verbesserte Prognose gegenüber der eingeschränkten Lymphadenektomie zu erwarten. Ursächlich für die schlechten Ergebnisse in der D2-Gruppe ist neben der hohen Rate von Pankreaslinksresektionen und Splenektomien die geringe Erfahrung der teilnehmenden Operateure und Kliniken. Da in Subgruppen ein Prognosegewinn zu erwarten ist und diese präoperativ nicht sicher bestimmt werden können, sollte die D2-Lymphadenektomie bei allen lokal fortgeschrittenen Karzinomen erfolgen. Die Indikation zur Splenektomie und/oder Pankreaslinksresektion muss aufgrund der Studienergebnisse sehr zurückhaltend gestellt werden.

Abstract

The appropriate extent of lymph node dissection during gastrectomy for cancer remains controversial. Even the Cochrane-Review analyzing the significance of D2-lymphadenectomy in gastric carcinoma does not come to a final evaluation. Recent studies from Japan and several Western centres have shown an improved survival rate in patients who underwent extensive lymph node dissection with curative intention. Two large European randomized trials only reported an increase in operative morbidity and mortality, but failed to show survival benefit, in the D2-lymphadenectomy group. Only for patients with N2-diseases the extended lymph node dissection may offer cure. Both randomized studies show that increased mortality in D2-lymphadenectomy is associated with high rates of spleen and pancreas resection, inexperience of the surgeon and surgery performed in centres with low case numbers. Since improvement of prognosis can be assumed for a subgroup of patients with gastric carcinoma, which can not be safely determined preoperatively, D2-lymphadenectomy should be performed in all cases of locally advanced gastric carcinoma. According to the results of recent studies, the indication for splenectomy and/or left pancreatic resection has to be applied very close.

Schlüsselwörter

Magenkarzinom - Lymphadenektomie - Morbidität - Prognose

Key words

gastric carcinoma - lymphadenectomy - surgical morbidity - prognostic factors

Literatur

  • 1 Arak A, Kull K. Factors influencing survival of patients after radical surgery for gastric cancer. A regional study of 406 patients over a 10-year period.  Acta Oncol. 1994;  33 913-920
    PubMedGoogle Scholar
  • 2 Bollschweiler E, Boettcher K, Hölscher A H. et al . Is the prognosis for Japanese and German patients with gastric cancer really different?.  Cancer. 1993;  71 2918-2925
    PubMedGoogle Scholar
  • 3 Bonenkamp J J, Songun I, Hermans J. et al . Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients.  Lancet. 1995;  345 745-748
    CrossrefPubMedGoogle Scholar
  • 4 Bonenkamp J J, Hermans J, Sasako M, de Velde C J van. Extended lymph-node dissection for gasteric cancer. Dutch gastric cancer group.  NEJM. 1999;  340 908-914
    CrossrefPubMedGoogle Scholar
  • 5 Bozzetti F, Marubini E, Bonfanti G. et al . Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group.  Ann Surg. 1997;  226 613-620
    CrossrefPubMedGoogle Scholar
  • 6 Brennan M F. Lymph node dissection for gastric cancer.  NEJM. 1999;  340 956-958
    CrossrefPubMedGoogle Scholar
  • 7 Bunt A MG, Hogendorn P CW, de Velde C JH, Bruijn J A van, Hermans J. Lymph node staging standards in gastric cancer.  J Clin Oncol. 1995;  13 2309-2316
    PubMedGoogle Scholar
  • 8 Csendes A, Burdiles P, Rojas J, Braghetto I, Diaz J C, Maluenda F. A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma.  Surgery. 2002;  131 401-407
    CrossrefPubMedGoogle Scholar
  • 9 Cuschieri A, Fayers P, Fielding J. et al . Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.  Lancet. 1996;  347 995-999
    CrossrefPubMedGoogle Scholar
  • 10 Cuschieri A, Weeden S, Fielding J. et al . Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Cooperative Group.  Br J Cancer. 1999;  79 1522-1530
    CrossrefPubMedGoogle Scholar
  • 11 De Almeida J C, Bettencourt A, Costa C S, de Almeida J M. Curative surgery for gastric cancer: study of 166 consecutive patients.  World J Surg. 1994;  18 889-894
    CrossrefPubMedGoogle Scholar
  • 12 Degiuli M, Sasako M, Ponti A, Calvo F. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer.  Br J Cancer. 2004;  90 1727-1732
    CrossrefPubMedGoogle Scholar
  • 13 Edwards P, Blackshaw G RJC, Lewis W G. et al . Prospective comparison of D1 vs modified D2 gastrectomy for carcinoma.  Br J Cancer. 2004;  90 1888-1892
    CrossrefPubMedGoogle Scholar
  • 14 Faß J, Hungs M, Reineke T, Nachtkamp J, Schumpelick V. Zur Frage der Prognoseverbesserung durch R1- und R2-Lymphadenektomie beim Magenkarzinom.  Chirurg. 1994;  65 867-872
    PubMedGoogle Scholar
  • 15 Gall F P, Hermanek P. Die systematische Lymphknotendissektion in der kurativen Therapie des Magenkarzinoms.  Chirurg. 1993;  64 1024-1031
    PubMedGoogle Scholar
  • 16 Gretschel S, Bembenek A, Ulmer C. et al . Lymphatic mapping und Sentinel-Lymphknotendiagnostik beim Magenkarzinom.  Chirurg. 2003;  74 132-138
    CrossrefPubMedGoogle Scholar
  • 17 Hannan E L, Radzyner M, Rubin D, Dougherty J, Brenann M F. The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer.  Surgery. 2002;  131 6-15
    CrossrefPubMedGoogle Scholar
  • 18 Hartgrink H H, de Velde C JH, Putter H. et al . Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized dutch gastric cancer group trial.  JCO. 2004;  22 2069-2077
    CrossrefPubMedGoogle Scholar
  • 19 Hermanek P. Lymphadenectomy: pathological aspects.  Langenbecks Arch Chir Ver Dtsch Ges Chir. 1996;  113 (Suppl II) 64-69
    PubMedGoogle Scholar
  • 20 Hermanek P. Lymph nodes and malignant tumor disease.  Zbl Chir. 2000;  125 790-795
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Hölscher A H, Bollschweiler E. Ausmaß von Resektion und Lymphadenektomie beim Magenkarzinom - eine anhaltende Kontroverse.  Onkologe. 1998;  4 301-309
    PubMedGoogle Scholar
  • 22 Huscher C G, Mingoli A, Sgarzini G. et al . Videolaparoscopic total and subtotal gastrectomy with extended lymph node dissection for gastric cancer.  Am J Surg. 2004;  188 728-735
    CrossrefPubMedGoogle Scholar
  • 23 Japanese classification of gastric carcinoma. 2nd English edition.  Gastric Cancer. 1998;  1 10-24
    CrossrefPubMedGoogle Scholar
  • 24 Japanese Research Society for Gastric Cancer .Tretament results of gastric carcinoma in Japan. 39th Report of nationwide registry. 1995
    Google Scholar
  • 25 Jatzko G R, Lisborg P H, Denk H, Klimpfinger M, Stettner H M. A 10 year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan.  Cancer. 1995;  76 1302-1312
    PubMedGoogle Scholar
  • 26 Karpeh M S, Leon L, Klimstra D, Brennan M F. Lymph node staging in gastric cancer: is location more important than number?.  Ann Surg. 2000;  232 362-371
    CrossrefPubMedGoogle Scholar
  • 27 Kitagawa Y, Fujii H, Mukai M, Kuboto T, Otani Y, Kitajima M. Radio-guided sentinel node dissection for gastric cancer.  Br J Surg. 2002;  89 604-608
    CrossrefPubMedGoogle Scholar
  • 28 Kitagawa Y, Burian M, Kitajima M. Zur Methodik des Sentinel Lymph Node Mapping.  Chirurg. 2004;  75 751-755
    PubMedGoogle Scholar
  • 29 Kodera Y, Yamamura Y, Torii A. et al . Postoperative staging of gastric carcinoma.  Scand J Gastroenterol. 1996;  31 476-480
    PubMedGoogle Scholar
  • 30 Kodera Y, Yamamura Y, Shimizu Y. et al . Lack of benefit of combined pancreaticosplenectomy in D2 resection for proximal-third gastric carcinoma.  World J Surg. 1997;  21 622-627
    CrossrefPubMedGoogle Scholar
  • 31 Lee W J, Lee W C, Houng S L. et al . Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: twenty years experience in Taiwan.  World J Surg. 1995;  19 707-725
    CrossrefPubMedGoogle Scholar
  • 32 Lewis W G, Edwards P, Barry J D. et al . D2 or not D2? The gastrectomy question.  Gastric Cancer. 2002;  5 29-34
    CrossrefPubMedGoogle Scholar
  • 33 Lisborg P, Jatzko G, Horn M. et al . Radical surgery (R2 resection) for gastric cancer. A multivariate analysis.  Scand J Gastroenterol. 1994;  29 1024-1028
    PubMedGoogle Scholar
  • 34 Llanos O, Guzman S, Pimental F, Ibanez I, Duarte I. Results of surgical treatment of gastric cancer.  Dig Surg. 1999;  16 385-388
    CrossrefPubMedGoogle Scholar
  • 35 Maehara Y, Tomoda M, Tomisaki S. et al . Surgical treatment and outcome for node-negative gastric cancer.  Surgery. 1997;  121 633-639
    CrossrefPubMedGoogle Scholar
  • 36 Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K. Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer.  Br J Surg. 2000;  87 353-357
    CrossrefPubMedGoogle Scholar
  • 37 Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. General pattern in 1 931 patients.  Ann Surg. 198;  210 596-602
    PubMedGoogle Scholar
  • 38 McCulloch P, Nita M E, Kazi H, Gama-Rodrigues J. Extended versus limited lymph nodes dissection technique for adeneocarcinoma of the stomach (Review).  Cochrane Database Syst Rev. 2004;  18 CD001964
    PubMedGoogle Scholar
  • 39 Miwa K, Kinami S, Taniguchi K, Fushida S, Fujimura T, Nonomura A. Mapping sentinel nodes in patients with early-stage gastric carcinoma.  Br J Surg. 2003;  90 178-182
    CrossrefPubMedGoogle Scholar
  • 40 Mönig S P, Zirbes T K, Schröder W. et al . Staging of gastric cancer: correlation of lymph node size and metastatic infiltration.  Am J Roentgenol. 1999;  173 365-367
    PubMedGoogle Scholar
  • 41 Mönig S P, Collet P H, Baldus S E. et al . Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus.  J Surg Oncol. 2001;  76 89-92
    CrossrefPubMedGoogle Scholar
  • 42 Noguchi Y, Imada T, Matsumoto A, Coit D G, Brennan M F. Radical surgery for gastric cancer: a review of the Japanese experience.  Cancer. 1989;  64 2053-2062
    CrossrefPubMedGoogle Scholar
  • 43 Onate-Ocana L F, Aiello-Crocifoglio V, Mondragon-Sanchez R, Ruiz-Molina J M. Survival benefit of D2 lymphadenectomy in patients with gastric adenocarcinoma.  Ann Surg Oncol. 2000;  7 210-217
    PubMedGoogle Scholar
  • 44 Pacelli F, Doglietto G B, Bellantone R, Alfieri S, Sgadari A, Crucitti F. Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients.  Br J Surg. 1993;  80 1153-1156
    PubMedGoogle Scholar
  • 45 Roder J D, Boettcher K, Siewert J R. Results of the German Gastric Cancer Study, multivariate analysis of potentially factors of 1 654 resected patients. In: Nishi M, Sugano H, Takahashi T (Eds). International Gastric Cancer Congress. Monduzzi Editore, Bologna, Italy 1995; 47-54
    Google Scholar
  • 46 Roukos D H, Baltogiannis G, Cassioumis D. Prognostic relevance of systematic lymph node dissection in gastric carcinoma.  Br J Surg. 1995;  82 1287-1289
    PubMedGoogle Scholar
  • 47 Roukos D H, Lorenz M, Encke A. Evidence of survival benefit of extended (D2) lymphadenectomy in Western patients with gastric cancer base on a new concept: a prospective long-term follow-up study.  Surgery. 1998;  1253 573-578
    PubMedGoogle Scholar
  • 48 Sano T, Sasako M, Yamamoto S. et al . Gastric cancer surgery: morbidity and mortality results from a prospective controlled trial comparing D2 and extended para-aortic lymphadenectomy - Japan Clinical Oncology Group Study 9501.  JCO. 2004;  14 2767-2773
    PubMedGoogle Scholar
  • 49 Sasako M, McCulloch P, Kinoshita T, Maruyama K. New method to evaluate the therapeutic value of lymph node dissection for gastric cancer.  Br J Surg. 1995;  82 346-351
    PubMedGoogle Scholar
  • 50 Schmidt-Matthiesen A, Beyer P A. Intraoperative macroscopical evaluation of lymph node metastases in gastric cancer patients.  Zbl Chir. 1996;  121 121-125
    PubMedGoogle Scholar
  • 51 Sendler A, Etter M, Böttcher K, Siewert J. Resektionsausmaß in der Chirurgie des Magenkarzinoms.  Chirurg. 2002;  73 316-324
    CrossrefPubMedGoogle Scholar
  • 52 Shchepotin I, Evans S R, Shabahang M. et al . Radical treatment of locally recurrent gastric cancer.  Am Surg. 1995;  61 371-376
    PubMedGoogle Scholar
  • 53 Sierra A, Regueira F M, Hernandez-Lizoain J L, Pardo F, Martinez-Gonzalez M A, A-Cienfueges J. Role of extended lymphadenectomy in gastric cancer surgery: experience in a single institution.  Ann Surg Oncol. 2003;  10 219-226
    CrossrefPubMedGoogle Scholar
  • 54 Siewert J R, Boettcher K, Roder J, Busch R, Hermanek P, Meyer H J. Prognostic relevance of systematic lymph node dissection in gastric carcinoma.  Br J Surg. 1993;  80 1015-1018
    PubMedGoogle Scholar
  • 55 Siewert J R, Stein H J, Böttcher K. Lymphadenektomie bei Tumoren des oberern Gastrointestinaltraktes.  Chirurg. 1996;  67 877-888
    PubMedGoogle Scholar
  • 56 Siewert J R, Kestlmeier B, Busch R. et al . Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases.  Br J Surg. 1996;  83 1144-1147
    PubMedGoogle Scholar
  • 57 Siewert J R, Böttcher K, Stein H, Roder J D. Relevant prognostic factors in gastric cancer.  Ann Surg. 1998;  228 449-461
    CrossrefPubMedGoogle Scholar
  • 58 Sobin L H, Wittekind C. TNM Classification of Malignant Tumours. Sixth Edition. Wiley-Liss, New York 2002; 65-68
    Google Scholar
  • 59 Tonouchi H, Mohri Y, Tanaka K. et al . Lymphatic mapping and sentinel node biopsy during laparoscopic gastrectomy for early cancer.  Dig Surg. 2003;  20 421-427
    CrossrefPubMedGoogle Scholar
  • 60 Wanebeo H J, Kennedy B J, Chmiel J, Steele G, Wichester D, Osteen R. Cancer of the stomach, a patient care study by the American College of Surgeons.  Ann Surg. 1993;  218 583-592
    CrossrefPubMedGoogle Scholar
  • 61 Wu C W, Hsiung C A, Lo S S, Hsieh M C, Shia L T, Whang-Peng J. Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer.  Br J Surg. 2004;  91 283-287
    CrossrefPubMedGoogle Scholar
  • 62 Yasuda K, Adachi Y, Shiraishi N, Inomata M, Takeuchi H, Kitano S. Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer.  Ann Surg Oncol. 2002;  9 771-774
    CrossrefPubMedGoogle Scholar

Priv.-Doz. Dr. med. Stefan P. Mönig

Klinik und Poliklinik für Visceral- und Gefäßchirurgie · Universität zu Köln

Kerpener Straße 62

50937 Köln (Lindenthal)

Phone: 02 21/4 78 48 03

Fax: 02 21/4 78 62 58

Email: stefan.moenig@uk-koeln.de

      >